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3Department of NMR Spectroscopy, University Hospital, Dijon, France
Objectives: In this paper, we present ProstateAnalyzer, a new web-based medical tool for
prostate cancer diagnosis. ProstateAnalyzer allows the visualization and analysis of
magnetic resonance images (MRI) in a single framework.
Methods: ProstateAnalyzer recovers the data from a PACS server and displays all the
associated MRI images in the same framework, usually consisting of 3D T2-weighted
imaging for anatomy, dynamic contrast-enhanced MRI for perfusion, diffusion-weighted
imaging in the form of an apparent diffusion coefficient (ADC) map and MR
Spectroscopy. ProstateAnalyzer allows annotating regions of interest in a sequence
and propagates them to the others.
Results: From a representative case, the results using the four visualization platforms
are fully detailed, showing the interaction among them. The tool has been implemented
as a Java-based applet application to facilitate the portability of the tool to the different
computer architectures and software and allowing the possibility to work remotely via
the web.
Conclusion: ProstateAnalyzer enables experts to manage prostate cancer patient data
set more efficiently. The tool allows delineating annotations by experts and displays all
the required information for use in diagnosis. According to the current European
Society of Urogenital Radiology guidelines, it also includes the PI-RADS structured
reporting scheme.
Keywords Applications, database management system, magnetic resonance imaging,
magnetic resonance spectroscopy, medical informatics, prostate cancer
BACKGROUND
Prostate cancer (PCa) has become a significant health care burden (1). Early
diagnosis and active follow-up allow improved prognosis and prevent life-
threatening conditions. Once the decision of treatment is taken, having the
most complete set of information for treatment and then for follow up is
crucial. Among the techniques used to detect and diagnose PCa, magnetic
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resonance imaging (MRI) allows the non-invasive analysis of the anatomy and
the metabolism in the entire prostate gland. The prostate is composed of
peripheral (PZ), central (CZ), transition (TZ), and anterior fibromuscular
tissue (AFT) zones (Figure 1). The PZ represents up to 70% of a normal
prostate gland and around 75% of prostate cancers originate in this zone. The
CZ represents about 25% of a normal healthy prostate gland in a young adult.
Even if the frequency of cancers originating here is much lower, they tend to be
of the more aggressive type (2).
MRI has been established as the best imaging modality for the detection,
localization, and staging of PCa on account of its high resolution and excellent
spontaneous contrast of soft tissues and the possibilities of multiplanar and
multiparameter scanning (3). As such, three MRI techniques (anatomic 3D
T2-weighted, diffusion-weighted, and perfusion-weighted imaging) and 3D
MR spectroscopy will be illustrated in this paper. A 3D T2-weighted imaging
(T2WI) sequence (4) yields good contrast between PZ and CZ tissues. Diffusion-
weighted imaging (DWI) provides functional information of tissues such as cell
organization, density and microstructure, and depends principally on the
Brownian motion of water molecules (5). It can be displayed either as native
diffusion-weighted images or as the ADC parametric map. The motion of water
molecules is more restricted in tissues with a high cellular density and intact
cell membranes and very low values are clearly indicative of cancer (6).
Perfusion imaging is based on the dynamic contrast enhancement (DCE) of the
signal during the first pass of the contrast agent. The theoretic underpinnings
of this vascular technique are based on tumor angiogenesis. In fact, there is a
relationship between abnormal perfusion and neoangiogenesis in tumors
(7–9). Magnetic resonance spectroscopy (MRS) is a technique that allows the
study of metabolite concentrations by means of a 3D chemical shift imaging
protocol (10). This study is useful since healthy and cancer tissues show
different concentration levels. Specifically, prostate cancer tissues show lower
levels of citrate and higher levels of choline compared with healthy tissue
(11–15) and metabolic data are often presented in the form of concentration
ratios, e.g. [Choline + Creatine]/Citrate. The exact ratio can vary with equip-
ment and settings. For example, ratios at 3 T differ slightly from those at 1.5 T
because of differences in the shape of the citrate spectrum (16). However, it is
generally accepted that PZ zone voxels, in which the ratio of choline and
creatine to citrate is at least two SDs higher than the average ratio in healthy
tissues, are considered to represent possible cancer (17). Voxels are considered
Figure 1. Anatomy of the prostate in (a) transversal and (b) sagittal planes.


















































highly suggestive of cancer if the ratio of choline and creatine to citrate is more
than three SDs higher than the average ratio (18).
The increasing amount of data available to analyze a study has not been
accompanied with the development of a single standardized way to report it.
Often the reports have been unstructured and in a narrative way (19).
However, the European Society of Urogenital Radiology (ESUR) has recently
proposed the Prostate Imaging-Reporting and Data System (PI-RADS) as the
standard structured reporting scheme for prostate cancer (10). Although other
schemes exist, such as the Likert score (20), the use of PI-RADS is rapidly
extending (21–24). Therefore, we included in our tool the possibility to use this
reporting scheme.
The medical support systems used to assist the diagnosis of prostate lesions
are generally focused on prostate segmentation (25–28). They rely on
computerized techniques for prostate cancer detection applied to ultrasound,
magnetic resonance, and computed tomodensitometric images (29). For
example, Vos et al. (30) used 3D-T2 imaging to define specific regions of
interest (ROI), which were subsequently used on diffusion- and perfusion-
weighted images to extract relevant features. The purpose was to train and
classify the extracted set of features to calculate the likelihood of malignancy.
Other related surveys have been focused on magnetic resonance spectroscopic
data (31). The rapid growth of computer-based clinical exams has seen a
significant increase in the number of online medical imaging systems (32,33),
some of which being developed as web-based applications (34). The main
challenge is the access and the interaction between the hospital database and
the distant users. Thus, the aim of our work was to develop a new architecture
system allowing including a web-based application connected to a prostate
image database.
In the field of biomedical informatics, one of the long standing problems is
finding a way to share medical data across a variety of media. Inherently,
medical data are generated by a multitude of sources (35,36). eXtensible
Markup Language (XML) has emerged as a leading facilitator. Although the
XML is provided with predefined tags, one of its advantages is its extensible
use. Over the last few years, a set of standards in the medical domain has been
developed, called medical markup language (MML) to allow the exchange of
medical data between different medical information providers (37,38).
Therefore, the XML schema of tags can be defined for each individual case.
Finally, the inclusion of the XML databases facilitates the management of
XML files by storing them in an efficient way (39). Traditional object relational
techniques, based on an XML model, are used to store XML files in an eXist-db
database (40).
PRIMARY OBJECTIVES
In this paper, we propose a new medical tool in the form of an interactive JAVA
applet application called Prostate-Analyzer. The purpose is to facilitate the
inclusion of medical findings on existing prostate images using the combin-
ation of MRI techniques and MR Spectroscopy. The novelty of our proposed
framework is that it includes the use of MRI and MRS in a compact
application. Generally, users have different tools to evaluate prostate images


















































for MRI and MRS. However, it is necessary to compare regions of interest at
the same time in order to determine pathologies or prostate lesions. For this
reason, it is more efficient for each modality to provide a single tool that can
easily manage all the data.
The main objective of the ProstateAnalyzer system is to develop a new tool
that encompasses the visualization and analysis of prostate MR images, as
well as a new storage system of clinical diagnoses in a single package. The tool
is able to characterize the morphological (location, shape, and size) and the
imaging features (mean and standard deviation of the signal, area, and center
of mass) of a region within the image, defined and annotated by an expert.
Furthermore, it calculates the signal-time curve in perfusion studies and
displays the LCModel signal spectrum for spectroscopic analysis (41). Besides,
it allows the analysis of the same image by different experts, an essential
feature in order to obtain a robust evaluation. The final outcome of the analysis
is summarized in terms of the PI-RADS protocol.
With regard to the proposed architecture for storage of medical images,
this should guarantee the connection and a secured access to the server, the




Three-dimensional T2-weighted fast spin-echo (TR/TE/ETL: 3600 ms/143 ms/
109, slice thickness: 1.25 mm) images (T2WI) were acquired with sub-
millimetric pixel resolution in an oblique axial plane. DWI (TR/TE: 4200/
101 ms) was performed using a pulsed gradient spin-echo technique with two
b-values (100 and 800 s/mm2). A parametric image, the ADC map, was directly
generated (on the vendor’s MRI consol) from the raw data on a pixel-by-pixel
basis using the formula:
S ¼ S0 expð1 bDÞ
where S0 represents signal intensity when b¼ 0 and D is the ADC directly
displayed as a gray scale number expressed in units of 106 mm2/s.
The protocol was completed with DCE-MRI performed using a fat
suppressed 3D T1 VIBE sequence (TR/TE/Flip angle: 3.25 ms/1.12 ms/100;
temporal resolution: 6 s/slab over approximately 5 min). A bolus injection of
Gd-DTPA (Dotarem, Guerbet, Roissy, France) was administered at a dose of
0.2 ml Gd-DTPA/kg of body weight. Finally, three-dimensional MR spectro-
scopic data were acquired using a water and lipid-suppressed sequence. Data
sets were composed of 16 16 16 phase-encoded spectral arrays giving
nominal spectral resolution of 0.14 cm3. Spectral data were processed using
a modified version of LCModel (S. Provencher Inc., Asbestos, QC) for 1H
spectroscopy of the prostate at 3T. Choline, creatine, and citrate were all
quantified individually.
ProstateAnalyzer application
ProstateAnalyzer is a network-based database system whose aims are the man-
agement and processing of both MRI and MRS data sets in a single package.


















































This tool is implemented as a Java-based applet application to facilitate the
inclusion of medical findings on existing prostate studies.
Architecture
A system has been designed in order to link the ProstateAnalyzer application
to a database of DICOM images and a XML server, which stores the annotated
files of the DICOM images. This architecture is supported by a Zend Server in
order to allocate the ProstateAnalyzer application and a XML database
provided by eXist-db (40). This type of architecture has been used in previous
works for supporting other modalities of medical imaging databases such as
PACS (42).
The ProstateAnalyzer application (Figure 2) communicates via socket
TCP/IP with the Apache Server provided by Zend Server. This server is
connected to a DICOM database, containing DICOM prostate images and with
the eXist-db database, containing the XML files. We opted for the creation
of the XML annotation files in the database in order to preserve the integrity
of the original DICOM database (usually stored in a PACS system).
Furthermore, in order to avoid vulnerabilities during the transfer of
information, internal security measures have been implemented. Besides
using control User ID private keys, the algorithms have systems that protect
and encrypt the information during its transmission. Currently, the secure
socket layer (SSL) cryptographic protocol is used (43). Finally, the users
can download the complete analysis performed by one user in a PDF file such
a pre-medical report.
XML database
The ProstateAnalyzer application is related to the eXist-db manager, respon-
sible for the XML database, incorporating its own server for access and
management via web interface. We also opted for the creation of the XML
Figure 2. Network-based database system designed to implement the framework and
the used hardware. The Zend server allows easy integration of the Apache server with
database management tools.


















































annotation files in the database. Again, all XML files are related to their
corresponding DICOM images and contain the records provided by experts.
Figure 3 shows a scenario of the use of the eXist-db XML database. The
database is configured at different levels in order to store XML files associated
with studies, collections, status and images. First, the ProstateAnalyzer
application connects with the eXist-db to access a study, where each study
contains a set of XML collections corresponding to 3DT2, DWI (as ADC map),
and DCE techniques. Consequently, for each dataset, all the XML files
concerning prostate images are allocated. It is important to note that each
XML file contains the annotations provided by all the experts. In this way, the
main structure of the XML file is the same for the images of the same study,
thus enabling a faster access to the annotated information.
Moreover, at the status level, for each study, a XML file associated with each
user is saved. Consequently, once the user is logged into the ProstateAnalyzer,
the corresponding XML file is obtained.
Security and system access
ProstateAnalyzer is designed as a web application; hence the connection
between the applet and the server can be both internal and external. The
actual login process consists in an authentication measure with a unique
username and password. One of the key elements in this application concerns
the security of the data and the information across the network. In this sense,
internal security measures to avoid vulnerabilities from the transfer of
information are already included in the Zend Server.
HTTP was originally designed for the transmission and reproduction of
multimedia documents, but these encodings are not part of the HTTP standard.
Figure 3. Connections to the eXist XML database within the ProstateAnalyzer and its
interaction with the user.


















































It is up to the applications themselves to break down and reassemble the
information in order to transmit and receive it. Fortunately, Java applets are
inherently based on the Internet Inter-ORB Protocol (IIOP). This protocol is
based on the client/server computing model and a security algorithm is
implemented as a security mechanism to ensure the integrity of the medical
data being transferred. In the literature, several architectures use the IIOP
in their security applications (19,44).
The most widely used regulations with respect to privacy and security are
the Health Insurance Portability and Accountability Act (HIPAA) and the
European Data Protection Directive 95/46/EC. Both regulations mandate
health institutions to protect health information against unauthorized use or
disclosure (45). In ProstateAnalyzer, the login/password signature allows
knowledge of who is dealing with the individual data. Therefore, an audit-log
for each study is produced identifying the user who has read the data and
thereby allowing one to generate audit trails on data access activities for any
specific patient (46).
ProstateAnalyzer engine
The search engine is the front-end for users once ProstateAnalyzer is accessed.
There are two types of patient searches: search for all the patients and an
advanced search. In the first option, the search engine returns a list with all
the patients recorded in the database. In the second case, the system returns
just the patients who share the same regular expression used as a query. To
perform a search, it is necessary to create a data set that contains information
concerning the four MR modalities described before. For each item, the tool
shows different attributes (patient name, comments, and status) and the
number of images provided by the concerned modality (anatomy, diffusion,
perfusion, and spectroscopy). Moreover, each case is represented by a different
color depending on the status of the study. When a state is color-coded as
yellow, it means that the study has been analyzed partially; a green color-
coding indicates that the study has been completely analyzed and validated.
Finally, white represents a study that has not yet been analyzed.
Anatomy 3D-T2WI
ProstateAnalyzer offers a new visualization platform to provide annotations
for different kinds of tissues (tumor number 1, tumor number 2, PZ, CZ, TZ, or
others) obtained from T2WI studies. This visualization capability is combined
with basic post-processing tasks such as zooming, gamma correction, user-
specific ROI, surface, and volumetric measurements. In addition, the viewer
provides information from the DICOM header, the status of the anatomical
study (validated, partial, or empty) and the list of the annotations added by
different users.
Figure 4(a) shows an example of visualization of the T2WI in prostate
cancer analysis. When an overlay is manually drawn, a label is automatically
defined with the user’s specified color. This label is defined using the first
letter of the user’s first name and surname followed by the number of
annotations (in the figure, the first region of interest is identified by letters
‘‘AL0’’ in green). A table shows a list of color-coded overlays, specifying the
username and the tissue type (indicated by the user). It also allows us to



































































































































































































































































































































































visualize or to delete each overlay, although this latter option is only available
to the expert who created it. Selecting an overlay of the table allows displaying
its related information (the annotations filled in a pop-up window). Finally,
after pressing the confirmation button of the pop-up window, the overlay is
added to the table, displayed on the image and stored in the XML database.
DWI
ProstateAnalyzer also provides a support tool for the DWI studies with similar
basic post-processing tasks as presented previously for T2WI. Figure 4(b)
shows an example of an ADC map with annotations provided by different
users. In the example, a multiple user-specific region of interest (ROI) study is
presented.
Perfusion imaging analysis (DCE)
Dynamic contrast enhanced (DCE) MRI is also catered for in the
ProstateAnalyzer. The tool also contains basic post-processing tasks using
the same features applied in T2WI and DWI. The most important difference
with respect to the other techniques is that the perfusion images are displayed
in time–space partitions.
Furthermore, this viewer uses a mean signal–time curve to display the
signal enhancement during the arrival of the contrast agent into the tissue.
Figure 4(c) shows an example of the ROI analysis in perfusion MR images. For
each overlay, the mean signal from each ROI is calculated and displayed as the
corresponding signal-time curve: the mean–curve is denoted with a different
color according to its associated area.
MRS
ProstateAnalyzer offers individual spectrum visualization from a 3D spectro-
scopic grid. Figure 4(d) presents an example of a MRS study with a LC Model-
processed signal spectrum. This viewer displays a set of 3D-T2 images allowing
the spatial location of the spectroscopy study. For each spectroscopic grid,
there is a corresponding image. In order to obtain a specific spectrum, the user
must click on the corresponding voxel (highlighted in red) within the grid. The
LC model is widely used for processing clinical single and multi-voxel
spectroscopic data (47). It allows individual and batch analyses of the main
metabolites within the spectra of the prostate: citrate, choline, creatine, and
spermine.
Interaction between spectroscopy and anatomy
One of the most important features of ProstateAnalyzer is the interaction of
the imaging modalities among themselves. Figure 5 shows an example of the
interaction between MRS and T2WI. The aim is to display the annotations,
obtained from the T2WI study panel, on the spectrum illustrated within the
graphical window. The way to link the processing is provided by the slice
location (it is shown in the DICOM information panel of the MRS image, and
boarded in yellow). In the MRS study panel, when the expert selects a voxel
within the spectroscopic grid, the spectrum is displayed. The next step is to
determine whether the selected voxel contains any annotations from the
anatomical 3D-T2 panel. If the information exists, it is displayed in the
































































































































































spectroscopic graphical area along with the spectrum. The example shows the
selected voxel corresponding to an area (in the anatomic analysis) with two
denominations for one tissue (named as Tum1 and CG in the figure), and is
also represented on the annotation table. This interaction is very important,
because one can visualize the information of both techniques in only one
representation.
Interaction between anatomy and perfusion
In this case, the anatomic and perfusion studies are not using the same
reference image due to the differences in spatial resolution. Consequently, the
solution is to locate the image from a set of corresponding perfusion DCE-MRI
images, as close as possible, to the slice location of the anatomical 3D-T2
image.
Figure 6 shows an example of the analysis on a perfusion-weighted study
using the ROI drawn on the corresponding 3D-T2 image. On the interface of
the perfusion image analysis, when the ‘‘anatomy’’ button is pressed all the
annotations concerning the anatomy study are displayed. ProstateAnalyzer
adapts the annotated regions into the correct position in the perfusion image,
according to the spatial resolution and the pixel spacing. In order to
distinguish the overlays between perfusion and anatomy, the viewer displays
all the anatomy overlays and adds the prefix ‘‘A’’ before the label name.
Reporting
Once the study is analyzed, the findings need to be reported, if possible in a
standardized way. ProstateAnalyzer includes the PI-RADS structured report-
ing scheme, according to ESUR prostate MR guidelines in 2012 (10), which is
being established as the common protocol in European countries (21,22). The
use of a standardized graphic reporting scheme facilitates the communication
with referring colleagues, and it increases the quality and diagnostic value of
prostate analyses.
The inclusion of the PI-RADS is carried out using a form with a drop-down
list that includes the different answers of the PI-RADS question. Selecting the
option, the corresponding number is assigned. The report is saved in an
independent XML file and loaded into the XML database. The use of an
independent XML file allows a faster search when looking just for similar cases
in terms of PI-RADS scores. Besides, there is the option of downloading a PDF
file with that information.
MAIN OUTCOME
In this section, a complete example of use of the ProstateAnalyzer application
is presented. In order to display the environment of the application, the
obtained results using the four visualizations platform (T2WI, DCE, DWI,
and MRS) are fully detailed. The main purpose is to demonstrate the usability
of the ProstateAnalyzer application in the localization and the analysis of
a tumor, if present.
Clinical diagnosis
The upper image of Figure 7 shows an example of a localized tumor displayed
on T2WI. Prostate cancer usually shows low signal intensity on T2WI that is























































































































































well defined with respect to normal PZ zone tissue. However, it is not always
easy to localize a pathologic area. One of the advantages of the
ProstateAnalyzer application is to analyze the same study using other
techniques. Once a sequence of the T2WI is analyzed, the application offers
an efficient solution to compare the same ROI in DCE, DWI, and MRS. On the
DCE, the peak of the curve corresponds to the first pass of the contrast agent
and indicates the rapid uptake of the contrast agent, typically observed in
cancer tissue.
We compare the mean curve of a representative tumor tissue with that of
healthy tissue in Figure 8. The first curve (in yellow) is from tumor tissue and
the second from healthy tissue (in red). In this case, the first annotation
corresponds to a tumor region labeled as ‘‘PW0’’ which is made in the perfusion
panel. The second, which represents healthy tissue, is annotated in the
anatomical panel and displayed in the perfusion panel labeled as ‘‘A-PWO’’. In
the diffusion panel, the analysis also demonstrates the presence of a tumor
(Figure 9). It is important to notice that the user draw a different ROI as the
one in Figure 7. Indeed, the tumor will correspond to low signal (therefore, low
diffusion coefficient) on the ACD map.
On the MRS panel (Figure 10), the example shows a selected voxel
corresponding to an area of cancer tissue (Tum1). The LC Model-processed
Figure 7. Interaction between T2WI and DCE.
















































































































































































































































Figure 9. Example of a localized tumor is represented using diffusion-weighted imaging
of the same prostate study.
Figure 10. Example of the interaction between T2WI and MRS studies showing the
spectra of the cancer Voxel.


















































signal spectrum demonstrates how the signal is modeled in red from the
noisy signal in black. Hence the different peaks of the spectrum are easily
extractable. Illustrating graphically the levels of these metabolites is very
important, since cancerous tissue is characterized within the spectrum as
reduced citrate and elevated choline peaks. In the figure, the first two
consecutive peaks correspond to choline and creatine, while the third one
corresponds to citrate. It is clear that the relative levels of choline and creatine
are very different to those observed in normal healthy tissue (Figure 4d),
where higher levels of citrate and lower levels choline are observed.
Once the clinical diagnosis has been performed, users have the option to
create a MR reporting, as depicted in Figure 11. For each MR technique,
a ‘‘PI-RADS’’ button is available in the option panel. When it is pressed,
a window pop-up appears where the user can report the findings for each
technique according to the PI-RADS protocol.
Design effort benchmarks
ProstateAnalyzer is currently being used in the MR department of the
University Hospital of Dijon (France). The present working database is
composed of more than 1600 patient datasets. The time to access to the Java
Applet application (ProstateAnalyzer) by users is around 2–3 s in an intranet
environment. It has been tested with the following common internet web
browsers: Mozilla Firefox, Internet Explorer, Google Chrome, and Opera. It is
preferable to use the Java Deployment Toolkit 6.0.160.1.1 or superior and to
use the JavaTMPlatform SE 6 U16 6.0.160.1. The most time-consuming part
corresponds to loading a prostate study. A typical study consists of a set of
Figure 11. A window pop-up allows to report the case according to the PI-RADS
protocol.


















































64 anatomical images, 14 ADC images, 640 perfusion images, and a set of
spectroscopic data containing up to 1000 files. It is important to note that the
number of spectroscopic data files is very variable and depends on the prostate
size. The average of the time consuming is around 60–70 s to load and display
a typical prostate study with the data presented previously.
The search engine provided by ProstateAnalyzer is tested in order to obtain
the complete study. The timing response to retrieve a prostate study was
around 1 min including the corresponding XML-associated files. The time
necessary to record annotations on the database is around 3–5 s for anatomical
and diffusion images and around 12 s for perfusion images. The computational
cost is higher for the latter because of the need to calculate the signal-time
curve. In order to obtain a spectrum, the cost is around 5 s to display it in the
graphical window. Once the analysis is finished by the user, ProstateAnalyzer
takes around 4 s to save the XML file into the database.
With the new architecture, ProstateAnalyzer can also be accessed using
regular external network connections outside the intranet connection of the
hospital. We tested the connection from Girona in Spain (several hundreds of
kilometers from Dijon). Experiments were carried out by loading a large study
consisting of a set of 64 anatomical images, 15 ADC images, 720 perfusion
images, and a set of spectroscopic data containing up to 1200 files (corres-
ponding to around 150 MB of transferred data). We loaded the case several
times during a week, and the total elapsed time response varied between 100
and 130 s. When comparing the times provided by the internal and external
connections using the same study, the difference was found to be around
40–70 s. The difference was due to two main reasons. On one hand, it depends
on the instantaneous network load and on the other hand to the number of
users being connected to the ProstateAnalizer server. The main conflict, when
multiple users are connected, is in the downloading of the cases, since the
server must split the downloading process between the connected users.
However, once the study is loaded, the usability, visualization, and annotation
times are independent with respect to the number of users – they just depend
on their own machine, not on the server).
DISCUSSION
ProstateAnalyzer is a web-based application for the analysis of prostate
images using four MR modalities: T2WI, DWI, DCE, and MRS. One of the
most evident advantages of ProstateAnalyzer is that it allows simultaneous
analysis of a prostate study using the different modalities. It also provides an
interaction among them and MR spectroscopy. Since the application has been
designed to work with DICOM files, any equipment that operates under such
image standard can potentially be used with ProstateAnalyzer.
The principal problem encountered in the diagnosis of a prostate study is
the localization of a ROI-containing tumor tissue. Normally, experts use
different tools to validate the diagnoses using different software and make
many annotations in different files. This is not a practical solution to managing
abundant medical data. ProstateAnalyzer offers the solution, because it allows
experts to analyze prostate ROI on T2WI, DWI, DCE, and MRS panels within
the same application.


















































The development of the proposed interface has been made in such a way
that it is simple and intuitive to use for the users. The interface is divided in
four panels with the purpose of visualizing a patient study, simultaneously, for
the different techniques. The main objective was to provide useful tools for
experts to manage examinations with different types of images and data.
ProstateAnalyzer allows the annotation of findings provided by different
experts in the prostate. All annotations are saved in XML files associated with
the prostate images. Although a prostate study can be shared among all the
users, they can still validate or modify their own diagnosis in individual cases.
Finally, our tool offers the possibility to work remotely via the web and
represents an improvement in the data management. The access to the
ProstateAnalyzer should be provided to multiple users in order to make easier
both local and external connections. In order to facilitate this task, the
application is implemented as a JAVA applet tool. Thus, it is not necessary to
install any program on computers to run our interface unless users have a
browser that supports Java technology. Moreover, applets can be executed
from any operating system (Windows, Linux, and MAC) because they are
running in a Web browser. ProstateAnalyzer can be integrated in a server to
manage medical images stored in a prostate database.
ProstateAnalyzer still presents some limitations which will be addressed in
order to enrich the tool. For instance, in perfusion analysis, the tool uses a
mean DCE signal–time curve to display the signal enhancement during the
arrival of the contrast agent into the tissue. However, providing quantitative
values related to microvascular permeability, Ktrans or the diffusion space, e
could also be helpful. With regard to the spectroscopy section, the possibility of
displaying 2D and 3D metabolite maps will be addressed. For this task,
specialized spatial and spectral data processing methods, for which sources are
not commonly available, are needed (e.g. morphological analysis and spectral
characteristics of the observed metabolites). We are also trying to improve the
efficiency of the computational cost. One solution could be to load single frames
only, on the basis of their spatial correspondence, instead of the whole dataset.
This would also allow the possibility of automatically displaying the four
sequences simultaneously. Thus, when scrolling the slices, the information
will change simultaneously on the T2WI, DWI, DCE, and MRSI displays.
Taking into account how rapidly clinical databases are growing,
ProstateAnalyzer should be an important contribution to the management of
large databases. Indeed, the implementation of ProstateAnalyzer offers the
possibility to extend and adapt to other MR modalities. As a proof of concept,
this project is an adaptation from previous work based on mammography (42)
and it demonstrates that our approach is easily portable to other sources of
medical images. Finally, as ProstateAnalyzer allows downloading reports in
PDF format containing the annotations and graphical results (mean signal–
time curve and signal spectra), it should also be useful as a pre-report.
CONCLUSION
In this paper, we have presented ProstateAnalyzer, a new medical tool
that allows the evaluation of the prostate cancer in an effective
way. ProstateAnalyzer visualizes the different MRI techniques


















































(anatomy, diffusion, and perfusion) together with MR spectroscopy, and
automatically places annotations, made in one of the images, onto the
others. In addition, ProstateAnalyzer also includes the PI-RADS reporting
protocol, thereby offering the possibility to fully report the prostate study in a
standardized way.
It has been implemented as an interactive JAVA applet application with the
purpose of facilitating the inclusion of medical findings on existing prostate
images, using the combination of MRI techniques and MR spectroscopic
analysis. Furthermore, a new architecture is presented to store the medical
records in a XML database which stores a set of annotated files.
DECLARATION OF INTEREST
The authors report that they have no conflicts of interest. This work was
partially funded by the Spanish R+D+I Grant no. TIN2012-37171-C02-01.
C. Mata holds a Mediterranean Office for Youth mobility grant. Finally, the
Regional Council of Burgundy under the PARI 1 scheme sponsored this work.
REFERENCES
1. Schro¨der FH, Hugosson J, Roobol MJ, et al. Prostate-cancer mortality at 11 years of
follow-up. N Engl J Med 2012;366:981–90.
2. Verma S, Rajesh A. A clinically relevant approach to imaging prostate cancer:
review. Am J Roentgenol 2011;196:S1–10.
3. Chen M, Dang HD, Wang JY, et al. Prostate cancer detection: comparison of T2-
weighted imaging, diffusion-weighted imaging, proton magnetic resonance spec-
troscopic imaging, and the three techniques combined. Acta Radiol 2008;49:602–10.
4. Bitar R, Leung G, Perng R, et al. MR Pulse sequences: what every radiologist wants
to know but is afraid to ask. RadioGraphics 2006;26:513–37.
5. Kilic¸kesmez O, Cimilli T, Inci E, et al. Diffusion-weighted MRI of urinary bladder
and prostate cancers. Diagn Interv Radiol 2009;15:104–10.
6. Ren J, Huan Y, Wang H, et al. Diffusion-weighted imaging in normal prostate and
differential diagnosis of prostate diseases. Abdom Imaging 2008;33:724–8.
7. Jackson AS, Reinsberg SA, Sohaib SA, et al. Dynamic contrast-enhanced MRI for
prostate cancer localization. Br J Radiol 2009;82:148–56.
8. Bard RL. Dynamic contrast-enhanced mri atlas of prostate cancer. New Haven:
Springer; 2009.
9. Alonzi R, Padhani A, Allen C. Dynamic contrast enhanced MRI in prostate cancer.
Eur J Radiol 2007;63:335–50.
10. Barentsz JO, Richenberg J, Clements R, et al; European Society of Urogenital
Radiology. ESUR prostate MR guidelines 2012. Eur Radiol 2012;22:746–57.
11. Villeirs GM, Oosterlinck W, Vanherreweghe E, De Meerleer GO. A qualitative
approach to combined magnetic resonance imaging and spectroscopy in the
diagnosis of prostate cancer. Eur J Radiol 2010;73:352–6.
12. Cre´hange G, Parfait S, Liegard M, et al. Tumor volume and metabolism of prostate
cancer determined by proton magnetic resonance spectroscopic imaging at 3T
without endorectal coil reveal potential clinical implications in the context of
radiation oncology. Int J Radiat Oncol Biol Phys 2011;80:1087–94.
13. Cre´hange G, Maingon P, Gauthier M, et al. Early choline levels from 3-tesla MR
spectroscopy after exclusive radiation therapy in patients with clinically localized
prostate cancer are predictive of plasmatic levels of PSA at 1 year. Int J Radiat
Oncol Biol Phys 2011;81:407–13.


















































14. Parfait S, Walker PM, Cre´hange G, et al. Classification of prostate magnetic
resonance spectra using support vector machine. Biomed Signal Process Control
2012;7:499–508.
15. Testa C, Schiavina R, Lodi R, et al. Prostate cancer: sextant localization with
MR imaging, MR spectroscopy, and 11 C-choline PET/CT. Radiology 2007;244:
797–806.
16. Scheenen TW, Heijmink SW, Roell SA, et al. Three-dimensional proton MR
spectroscopy of human prostate at 3 T without endorectal coil: feasibility. Radiology
2007;245:507–16.
17. Verma S, Rajesh A, Fu¨tterer JJ, et al. Prostate MRI and 3D MR Spectroscopy: How
We Do It. Am J Roentgenol 2010;194:1414–26.
18. Jung JA, Coakley FV, Vigneron DB, et al. Prostate depiction at endorectal MR
spectroscopic imaging: investigation of a standardized evaluation system.
Radiology 2004;233:701–8.
19. Dickinson L, Ahmed HU, Allen C, et al. Scoring systems used for the interpretation
and reporting of multiparametric MRI for prostate cancer detection, localization,
and characterization: could standardization lead to improved utilization of imaging
within the diagnostic pathway? J Magn Reson Imaging 2013;37:48–58.
20. Villers A, Puech P, Mouton D, et al. Dynamic contrast enhanced, pelvic phased
array magnetic resonance imaging of localized prostate cancer for predicting tumor
volume: correlation with radical prostatectomy findings. J Urol 2006;176:2432–7.
21. Portalez D, Mozer P, Cornud F, et al. Validation of the European Society of
Urogenital Radiology scoring system for prostate cancer diagnosis on multi-
parametric magnetic resonance imaging in a cohort of repeat biopsy patients. Eur
Urol 2012;62:986–96.
22. Rosenkrantz AB, Kim S, Lim R, et al. Prostate cancer localization using
multiparametric MR imaging: comparison of Prostate Imaging Reporting and
Data System (PI-RADS) and Likert scales. Radiology 2013;269:482–92.
23. Roethke MC, Kuru TH, Schultze S, et al. Evaluation of the ESUR PI-RADS scoring
system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-
guided biopsy at 3.0 Tesla. Eur Radiol 2014;24:344–52.
24. Reisæter LA, Fu¨tterer JJ, Halvorsen OJ, et al. 1.5-T multiparametric MRI using
PI-RADS: a region by region analysis to localize the index-tumor of prostate cancer
in patients undergoing prostatectomy. Acta Radiol 2014.Q1 .
25. Shah V, Turkbey B, Mani H, et al. Decision support system for localizing prostate
cancer based on multiparametric magnetic resonance imaging. Med Phys 2012;39:
4093–103.
26. Dickinson L, Ahmed HU, Allen C, et al. Magnetic resonance imaging for the
detection, localisation, and characterisation of prostate cancer: recommendations
from a European consensus meeting. Eur Urol 2011;59:477–494.
27. Fradet V, Kurhanewicz J, Cowan JE, et al. Prostate cancer managed with active
surveillance: role of anatomic MR imaging and MR spectroscopic imaging.
Radiology 2010;256:176–83.
28. Ghose S, Oliver A, Mitra J, et al. A supervised learning framework of statistical
shape and probability priors for automatic prostate segmentation in ultrasound
images. Med Image Anal 2013;17:587–600.
29. Ghose S, Oliver A, Martı´ R, et al. A survey of prostate segmentation methodologies
in ultrasound, magnetic resonance and computed tomography images. Comput
Methods Prog Biomed 2012;108:262–87.
30. Vos PC, Hambrock T, Barenstz JO, Huisman HJ. Computer-assisted analysis of
peripheral zone prostate lesions using T2-weighted and dynamic contrast enhanced
T1-weighted MRI. Phys Med Biol 2010;55:1719–34.
31. Carroll PR, Coakley FV, Kurhanewicz J. Magnetic resonance imaging and
spectroscopy of prostate cancer. Rev Urol 2006;8:S4–10.
32. Oppelt A. Systems for medical diagnostics: fundamentals, technical solutions and
applications for systems applying ionizing radiation, nuclear magnetic resonance
and ultrasound. Germany: Publicis Publishing; 2005.


















































33. Madabhushi A, Dowling J, Huisman H, Barratt D, eds. Prostate cancer imaging.
Image analysis and image-guided interventions. Lecture notes in computer science;
2011Q2 .
34. Kurc T, Janies DA, Johnson AD, et al. An XML-based system for synthesis of data
from disparate databases. J Am Med Inform Assoc 2006;13:289–301.
35. Marcos E, Acun˜a CJ, Vela B, et al. A database for medical image management.
Comput Methods Prog Biomed 2007;86:255–69.
36. Tahmoush D, Samet H. A new database for medical images and information.
In: Proceedings of SPIE – medical imaging 2007: image processing 2007,
San Diego, CA.
37. Guo J, Araki K, Takada K, et al. The latest MML (Medical Markup Language)
version 2.3–XML-based standard for medical data exchange/storage. J Med Syst
2003;27:357–66.
38. Guo J, Takada A, Tanaka K, et al. The development of MML (Medical Markup
Language) version 3.0 as a medical document exchange format for HL7 messages.
J Med Syst 2004;28:523–33.
39. Lindsay, J. XML databases and biomedical informatics. Connecticut: University of
Connecticut; 2008.
40. Meier W. eXist: an open source native XML database in web, web-services, and
database systems. Germany: Springer; 2002:169–83.
41. Provencher SW. Estimation of metabolite concentrations from localized in vivo
proton NMR spectra. Magn Reson Med 1993;30:672–9.
42. Mata C, Oliver A, Torrent A, Martı´ J. MammoApplet: an interactive Java applet
tool for manual annotation in medical imaging. In: IEEE international conference
on bioinformatics and bioengineering, 2012, Larnaca, Cyprus: 34–9.
43. Sumathi S, Sivanandam SN. Introduction to data mining and its applications; 29 of
studies in computational intelligence. Germany: Springer; 2006.
44. Papadakis I, Chrissikopoulos V, Polemi D. Secure medical digital libraries. Int J
Med Inform 2001;64:1–8.
45. Zhou Z, Liu BJ. HIPAA compliant auditing system for medical images. Comput Med
Imaging Graph 2005;29:235–41.
46. Lee WB, Lee CD, Ho KI. A HIPAA-compliant key management scheme with
revocation of authorization. Comput Methods Prog Biomed 2014;113:809–14.
47. Provencher W. Automatic quantitation of localized in vivo 1H spectra with
LCModel. NMR Biomed 2001;14:260–4.
Web-based management of prostate cancer imaging 21
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
1001
1002
1003
1004
1005
1006
1007
1008
1009
1010
1011
1012
1013
1014
1015
1016
1017
1018
1019
1020
1021
1022
1023
1024
1025
1026
1027
1028
1029
